Roquefort Therapeutics plc logo

Roquefort Therapeutics plc (ROQ)

Market Closed
2 Jun, 15:30
LSE LSE
11. 75
GBX
0
0%
GBX
155.54K Market Cap
- P/E Ratio
- Div Yield
83,638 Volume
- Eps
11.75 GBX
Previous Close
Add Transaction
Day Range
11.43 12.5
Year Range
0.95 30
Want to track ROQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Roquefort Therapeutics plc logo
ROQ Roquefort Therapeutics plc
28 Apr 2026
-
-
Roquefort Therapeutics plc logo
ROQ Roquefort Therapeutics plc
25 Sep 2025
-
-
Roquefort Therapeutics plc logo
ROQ Roquefort Therapeutics plc
24 Apr 2025
-
-
Roquefort Therapeutics plc logo
ROQ Roquefort Therapeutics plc
25 Sep 2024
-
-
Roquefort Therapeutics plc logo
ROQ Roquefort Therapeutics plc
28 Jun 2024
-
-

ROQ Earnings Reports FAQ

What is the earnings per share (EPS) for ROQ?

EPS data for ROQ is currently not available, as Roquefort Therapeutics plc has not reported recent earnings.

What is the company's earnings growth rate?

Roquefort Therapeutics plc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Roquefort Therapeutics plc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Roquefort Therapeutics plc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ROQ at this time, as Roquefort Therapeutics plc has no recent EPS data to calculate it.